| Q55154317 | A Critical Review of the Bacterial Baptism Hypothesis and the Impact of Cesarean Delivery on the Infant Microbiome. |
| Q38644820 | A Review of Antibiotic Use in Pregnancy. |
| Q35028137 | A case for antibiotic perturbation of the microbiota leading to allergy development |
| Q26774686 | Advances in the Prevention of Infection-Related Preterm Birth |
| Q35852097 | Antepartum Antibiotic Treatment Increases Offspring Susceptibility to Experimental Colitis: A Role of the Gut Microbiota. |
| Q36157505 | Antibiotic Treatment and Length of Hospital Stay in Relation to Delivery Mode and Prematurity |
| Q90017758 | Antibiotic Use Without Indication During Delivery Hospitalizations in the United States |
| Q33611585 | Antibiotic exposure in pregnancy and risk of coeliac disease in offspring: a cohort study |
| Q39782737 | Antibiotic use during pregnancy and asthma in preschool children: the influence of confounding |
| Q42670065 | Antibiotic use during pregnancy: how bad is it? |
| Q34585065 | Antibiotics in fetal and early life and subsequent childhood asthma: nationwide population based study with sibling analysis |
| Q92999660 | Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders? |
| Q42218256 | Assessing the association of early life antibiotic prescription with asthma exacerbations, impaired antiviral immunity, and genetic variants in 17q21: a population-based birth cohort study |
| Q47188541 | Asthma and atopic dermatitis after early-, late-, and post-term birth |
| Q34741123 | Asthma microbiome studies and the potential for new therapeutic strategies |
| Q48003317 | Beta-2 receptor agonist exposure in the uterus associated with subsequent risk of childhood asthma. |
| Q35893084 | Childbirth and consequent atopic disease: emerging evidence on epigenetic effects based on the hygiene and EPIIC hypotheses |
| Q90149931 | Childhood inflammatory and metabolic disease following exposure to antibiotics in pregnancy, antenatally, intrapartum and neonatally |
| Q49714985 | Clinical Relevance of Gastrointestinal Microbiota During Pregnancy: A Primer for Nurses |
| Q40141382 | Clinical chorioamnionitis at term VIII: a rapid MMP-8 test for the identification of intra-amniotic inflammation. |
| Q35234881 | Combined effects of prenatal medication use and delivery type are associated with eczema at age 2 years |
| Q57638045 | DENND1B gene variants associate with elevated exhaled nitric oxide in healthy high-risk neonates |
| Q40719530 | Development and Implementation of an Early-Onset Sepsis Calculator to Guide Antibiotic Management in Late Preterm and Term Neonates |
| Q35655823 | Early microbial contact, the breast milk microbiome and child health |
| Q49501850 | Early microbiota, antibiotics and health. |
| Q90635449 | Establishment of the early-life microbiome: a DOHaD perspective |
| Q40100528 | Evolution, human-microbe interactions, and life history plasticity |
| Q58712925 | Expansion of commensal fungus Wallemia mellicola in the gastrointestinal mycobiota enhances the severity of allergic airway disease in mice |
| Q36239426 | Exploring the origins of asthma: Lessons from twin studies |
| Q34311486 | External influence of early childhood establishment of gut microbiota and subsequent health implications. |
| Q34667433 | Fecal microbiota transplantation broadening its application beyond intestinal disorders |
| Q35064289 | Folic acid protects against lipopolysaccharide-induced preterm delivery and intrauterine growth restriction through its anti-inflammatory effect in mice |
| Q93037597 | Functional effects of the microbiota in chronic respiratory disease |
| Q50077332 | Gastro-oesophageal reflux: a mixed methods study of infants admitted to hospital in the first 12 months following birth in NSW (2000-2011). |
| Q36487279 | Gut Microbiome and the Development of Food Allergy and Allergic Disease |
| Q35973879 | Gut Microbiota and Allergic Disease. New Insights |
| Q35355980 | Gut microbiota: a source of novel tools to reduce the risk of human disease? |
| Q35965468 | Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. |
| Q35642742 | Human seroreactivity to gut microbiota antigens |
| Q40987237 | Identification of Emerging Human Mastitis Pathogens by MALDI-TOF and Assessment of Their Antibiotic Resistance Patterns. |
| Q64119534 | Intestinal Microbiota in Early Life and Its Implications on Childhood Health |
| Q38971101 | Intestinal commensal bacteria mediate lung mucosal immunity and promote resistance of newborn mice to infection |
| Q33863396 | Lactobacilli and bifidobacteria in human breast milk: influence of antibiotherapy and other host and clinical factors |
| Q26781072 | Lessons Learned in Antibiotic Stewardship: Fluoroquinolone Use in Pediatrics |
| Q37739229 | Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior |
| Q35165937 | Lung microbiota promotes tolerance to allergens in neonates via PD-L1. |
| Q28552294 | Management of Prematurity-Associated Wheeze and Its Association with Atopy |
| Q88973404 | Maternal Cytokine Profiles during Pregnancy Predict Asthma in Children of Mothers without Asthma |
| Q43557844 | Maternal antibiotic use and risk of asthma in offspring--Authors' reply |
| Q90633161 | Maternal carriage of Prevotella during pregnancy associates with protection against food allergy in the offspring |
| Q38075784 | Maternal infection in pregnancy and risk of asthma in offspring |
| Q38419548 | Maternal propensity for infections and risk of childhood asthma: a registry-based cohort study |
| Q33871387 | Microbial 'old friends', immunoregulation and socioeconomic status. |
| Q35631743 | Microbiota in allergy and asthma and the emerging relationship with the gut microbiome |
| Q36082343 | Neonatal microbial colonization in mice promotes prolonged dominance of CD11b(+)Gr-1(+) cells and accelerated establishment of the CD4(+) T cell population in the spleen |
| Q34823038 | Parental celiac disease and risk of asthma in offspring: a Danish nationwide cohort study |
| Q35815847 | Periconceptional and Gestational Exposure to Antibiotics and Childhood Asthma |
| Q36216412 | Planting the seed: Origins, composition, and postnatal health significance of the fetal gastrointestinal microbiota |
| Q36694893 | Posttraumatic Stress Disorder: Does the Gut Microbiome Hold the Key? |
| Q35049465 | Prematurity and prescription asthma medication from childhood to young adulthood: a Danish national cohort study |
| Q38178801 | Prenatal and childhood infections: implications for the development and treatment of childhood asthma |
| Q38388797 | Prenatal antibiotic use and risk of childhood wheeze/asthma: A meta-analysis |
| Q38919109 | Prenatal antibiotics and atopic dermatitis among 18-month-old children in the Danish National Birth Cohort. |
| Q47941771 | Prenatal antimicrobial use and early-childhood body mass index |
| Q41652270 | Prenatal exposure to H2 blockers and to proton pump inhibitors and asthma development in offspring |
| Q35328729 | Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity |
| Q38161563 | Prevention of asthma: where are we in the 21st century? |
| Q38181858 | Probiotics for human lactational mastitis. |
| Q35682970 | Promising candidates for allergy prevention |
| Q35024885 | Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health |
| Q58729876 | Relationship between Maternal and First Year of Life Dispensations of Antibiotics and Antiasthmatics |
| Q35155854 | Relationship between prenatal antibiotic use and asthma in at-risk children |
| Q35966011 | Relative Importance and Additive Effects of Maternal and Infant Risk Factors on Childhood Asthma |
| Q64072372 | Risk factors and predisposing conditions for urinary tract infection |
| Q52603400 | Role of the Microbiome in Food Allergy. |
| Q38246106 | Safety of antimicrobial treatment during pregnancy: a current review of resistance, immunomodulation and teratogenicity |
| Q47573801 | Sex-specific impact of asthma during pregnancy on infant gut microbiota |
| Q59341020 | Strategies for the Preservation, Restoration and Modulation of the Human Milk Microbiota. Implications for Human Milk Banks and Neonatal Intensive Care Units |
| Q36182979 | The Central Nervous System and the Gut Microbiome. |
| Q37731038 | The Maternal Diet, Gut Bacteria, and Bacterial Metabolites during Pregnancy Influence Offspring Asthma |
| Q47638694 | The Role of Lower Airway Dysbiosis in Asthma: Dysbiosis and Asthma. |
| Q38246711 | The early use of appropriate prophylactic antibiotics in susceptible women for the prevention of preterm birth of infectious etiology |
| Q58716207 | The effect of breastfeeding on the risk of asthma in high-risk children: a case-control study in Shanghai, China |
| Q58161257 | The host microbiome and impact of tuberculosis chemotherapy |
| Q37057724 | The influence of maternal prenatal and early childhood nutrition and maternal prenatal stress on offspring immune system development and neurodevelopmental disorders |
| Q33754027 | The interplay between host immune cells and gut microbiota in chronic inflammatory diseases |
| Q90115661 | The matter of the reproductive microbiome |
| Q39447483 | The mother-offspring dyad: microbial transmission, immune interactions and allergy development |
| Q39402852 | The nutrition-gut microbiome-physiology axis and allergic diseases. |
| Q39444008 | The potential of anti-infectives and immunomodulators as therapies for asthma and asthma exacerbations. |
| Q41500147 | The skin microbiome: impact of modern environments on skin ecology, barrier integrity, and systemic immune programming. |
| Q30371116 | Wheezing exacerbations in early childhood: evaluation, treatment, and recent advances relevant to the genesis of asthma |
| Q89901817 | [Association between risk factors during maternal pregnancy and the neonatal period and childhood bronchial asthma] |